|
Volumn 53, Issue 6, 2000, Pages 667-674
|
No advantage of the new combined octreotide-GHRH test over established GH-stimulation tests in the diagnosis of growth hormone deficiency (GHD) in adults
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ARGININE;
GROWTH HORMONE;
GROWTH HORMONE RELEASING FACTOR;
OCTREOTIDE;
SOMATOMEDIN C;
ADULT;
ARTICLE;
CLINICAL ARTICLE;
DIAGNOSTIC ACCURACY;
DIAGNOSTIC PROCEDURE;
DIAGNOSTIC VALUE;
FEMALE;
GROWTH HORMONE DEFICIENCY;
HUMAN;
INSULIN HYPOGLYCEMIA;
INTERMETHOD COMPARISON;
LABORATORY DIAGNOSIS;
MALE;
PRIORITY JOURNAL;
RELIABILITY;
SCREENING TEST;
ADOLESCENT;
ADULT;
AGED;
AREA UNDER CURVE;
ARGININE;
FEMALE;
GROWTH HORMONE;
GROWTH HORMONE-RELEASING HORMONE;
HORMONES;
HUMANS;
INSULIN;
INSULIN-LIKE GROWTH FACTOR I;
MALE;
MIDDLE AGED;
OCTREOTIDE;
PITUITARY DISEASES;
PITUITARY FUNCTION TESTS;
PREDICTIVE VALUE OF TESTS;
SENSITIVITY AND SPECIFICITY;
|
EID: 0034490801
PISSN: 03000664
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1365-2265.2000.01113.x Document Type: Article |
Times cited : (4)
|
References (31)
|